Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
94 hedge funds and large institutions have $477M invested in Albireo Pharma Inc in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 38 increasing their positions, 31 reducing their positions, and 9 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 31
2% less call options, than puts
Call options by funds: $4.05M | Put options by funds: $4.12M
5% less funds holding
Funds holding: 99 → 94 (-5)
19% less capital invested
Capital invested by funds: $586M → $477M (-$109M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$6.48M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
+$4.64M |
| 3 |
CC
Chicago Capital
Chicago,
Illinois
|
+$3.79M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$1.41M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$39.4M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$8.79M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.61M |
| 4 |
Two Sigma Advisers
New York
|
-$2.56M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.22M |
ALBO Hedge Fund Activity: Q3 2021 in Review
94 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2021, worth a combined $477M — down 19% from $586M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ALBO and 4 opened new positions — a net loss of 5 holders — while 31 trimmed existing stakes and 38 added.
The largest buyer was State Street, adding an estimated $6.48M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $39.4M sold.
- 94 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2021, down from 99 in Q2 2021.
- Funds reported $477M of Albireo Pharma Inc stock for Q3 2021, down 19% quarter-over-quarter.
- 4 funds opened new Albireo Pharma Inc positions in Q3 2021 and 9 closed out, a net change of -5 holders.
- The largest Albireo Pharma Inc buyer in Q3 2021 was State Street, an estimated $6.48M added.
- The largest Albireo Pharma Inc seller in Q3 2021 was Two Sigma Investments, an estimated $39.4M sold.
Based on aggregated 13F filings for Q3 2021.